Idhifa
(enasidenib)IDHIFA 50 MG Oral TabletIDHIFA 100 MG Oral Tablet
Dosage & administration
100 mg orally once daily until disease progression or unacceptable toxicity .
biomarker testing
Idhifa clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type. drug label
Idhifa prescribing information
prior authorization
Idhifa prior authorization resources
Benefits investigation
Learn MoreBenefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Reimbursement help (FRM)
Learn MoreSome brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
pharmacy
Idhifa preferred pharmacy
financial assistance
Idhifa financial assistance options
Co-pay savings program
Learn MoreOverview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Foundation programs
Learn MoreOverview
- Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
- These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
- Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
- Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
- Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Idhifa patient education
Getting started on Idhifa
To share resource; ask patient to: 1.Pull out phone
2.Open camera
3.Scan QR code with camera
Other resources
Learn MoreOther resources brands publish to help support patients.
people also ask
Idhifa FAQs
How is the dosage of Idhifa?Idhifa is available in 2 dosages, including 100 mg Tab and 50 mg Tab
What does Idhifa treat?Idhifa treats Acute Myeloid Leukemia
What is Idhifa made of?Idhifa contains enasidenib which is a Isocitrate Dehydrogenase 2 Inhibitor
How Is Idhifa Administered?Idhifa is administered as a Oral Pill
What Are The Idhifa Mechanism Of Action?Idhifa mechanism of action is Isocitrate Dehydrogenase 2 Inhibitors
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
